Crossmark

Suitable Use of Injectable Agents to Overcome Hypoglycemia Risk, Barriers, and Clinical Inertia in Community-Dwelling Older Adults with Type 2 Diabetes Mellitus

Crossref DOI link: https://doi.org/10.1007/s40266-019-00706-4

Published Online: 2020-09-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Valencia, Willy M.

Florez, Hermes J.

Palacio, Ana M.
Funding

Funding for this research was provided by:

Sanofi
License Information

Text and Data Mining valid from 2019-12-01

Version of Record valid from 2020-09-08
More Information

Article History

First Online: 8 September 2020

Change Date: 9 September 2020

Change Type: Correction

Change Details: The article Suitable Use of Injectable Agents to Overcome Hypoglycemia Risk, Barriers, and Clinical Inertia in Community-Dwelling Older Adults with Type 2 Diabetes Mellitus, written by Willy M. Valencia, Hermes J. Florez and Ana M. Palacio was originally published Online First without open access.

Compliance with Ethical Standards

:

: Sponsor (Sanofi US Inc.) provided editorial support in the preparation and submission of this manuscript.

: Willy M. Valencia and Ana M. Palacio have nothing to declare. Hermes J. Florez is a consultant (in a scientific advisory capacity) for the SENIOR study.

Updates are available Correction dated 2020-09-09

Click to view Correction: https://doi.org/10.1007/s40266-020-00795-6